LNC
29
4
NAVI
40
7
R
61
2
GE
64
4
VNO
49
2
F
40
2
KO
46
4
PDCO
77
2
WAT
59
4
KMI
73
4
ADT
27
2
RCL
76
3
WU
16
4
MKC
53
2
CNX
71
3
ADSK
63
2
WY
37
3
BK
61
3
ROP
48
3
URI
39
3
LNC
29
4
NAVI
40
7
R
61
2
GE
64
4
VNO
49
2
F
40
2
KO
46
4
PDCO
77
2
WAT
59
4
KMI
73
4
ADT
27
2
RCL
76
3
WU
16
4
MKC
53
2
CNX
71
3
ADSK
63
2
WY
37
3
BK
61
3
ROP
48
3
URI
39
3
Financhill
Back

Rhythm Pharmaceuticals Vs. Neurogene Industry Stock Comparison

Sell
46

RYTM
Rhythm Pharmaceuticals

Last Price:
$55.81
Seasonality Move:
-14.94%
Sell
14

NGNE
Neurogene

Last Price:
$22.69
Seasonality Move:
23.27%
Sell
46
Rhythm Pharmaceuticals (RYTM) is a Sell

Is Rhythm Pharmaceuticals a Buy, Sell or Hold?

  • The current Rhythm Pharmaceuticals [RYTM] share price is $55.85. The Score for RYTM is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • RYTM is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
14
Neurogene (NGNE) is a Sell

Is Neurogene a Buy, Sell or Hold?

  • The current Neurogene [NGNE] share price is $22.62. The Score for NGNE is 14, which is 72% below its historic median score of 50, and infers higher risk than normal.
  • NGNE is currently trading in the 10-20% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing an extreme reading that indicates risk could be especially high.

RYTM Stock Price Chart

What is Rhythm Pharmaceuticals's stock price today?

  • The Rhythm Pharmaceuticals share price today is $55.85
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RYTM is experiencing slight buying pressure.

NGNE Stock Price Chart

What is Neurogene's stock price today?

  • The Neurogene share price today is $22.62
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NGNE is experiencing slight buying pressure.

RYTM Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.6 Sell
Relative Strength Index (14 RSI): 46.14 Sell
Chaikin Money Flow: 10036 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (55.82 - 60.58) Sell
Bollinger Bands (100): (46.59 - 58.07) Buy

NGNE Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.24 Sell
Relative Strength Index (14 RSI): 40.31 Sell
Chaikin Money Flow: 33416 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (19.65 - 25.15) Buy
Bollinger Bands (100): (25.64 - 49.84) Sell

RYTM Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 55.56 Buy
20-day SMA: 57.84 Sell
50-day SMA: 56.36 Sell
200-day SMA: 47.04 Buy
8-day EMA: 55.99 Sell
20-day EMA: 56.89 Sell
50-day EMA: 56 Sell
200-day EMA: 48.31 Buy

NGNE Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 23 Sell
20-day SMA: 23.46 Sell
50-day SMA: 36.34 Sell
200-day SMA: 37.73 Sell
8-day EMA: 22.79 Sell
20-day EMA: 24.82 Sell
50-day EMA: 31.38 Sell
200-day EMA: 34.77 Sell

Rhythm Pharmaceuticals Earnings Growth & RYTM Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.18 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.21 per share, and an increase next year of $1.77 per share.

Neurogene Earnings Growth & NGNE Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.04 per share.

Rhythm Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Neurogene Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):